Full Text

Turn on search term navigation

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

11H-Indeno[1,2-b]quinoxaline derivatives present an important type of nitrogen-containing heterocyclic compound that are useful intermediate products in organic synthesis and have potential pharmaceutical applications. A new 11H-indeno[1,2-b]quinoxalin-11-one-2-(4-ethylbenzylidene)hydrazone (compound 3) was synthesized. Compound 3 is the first example of an azine derivative based on the 11H-indeno[1,2-b]quinoxaline system. The Z,E-isomerism of compound 3 was investigated by DFT calculations. Bioavailability was evaluated in silico using ADME predictions. According to the ADME results, compound 3 is potentially highly bioavailable and has potential to be used for the treatment of neuroinflammation and ischemia–reperfusion injury.

Details

Title
11H-Indeno[1,2-b]quinoxalin-11-one 2-(4-ethylbenzylidene)hydrazone
Author
Kovrizhina, Anastasia R 1 ; Samorodova, Elizaveta I 1 ; Khlebnikov, Andrei I 2   VIAFID ORCID Logo 

 Kizhner Research Center, Tomsk Polytechnic University, 634050 Tomsk, Russia; [email protected] (A.R.K.); [email protected] (E.I.S.) 
 Kizhner Research Center, Tomsk Polytechnic University, 634050 Tomsk, Russia; [email protected] (A.R.K.); [email protected] (E.I.S.); Scientific Research Institute of Biological Medicine, Altai State University, 656049 Barnaul, Russia 
First page
M1299
Publication year
2021
Publication date
2021
Publisher
MDPI AG
e-ISSN
14228599
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2612809979
Copyright
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.